Quest Diagnostics Q4 2019 Earnings Report
Key Takeaways
Quest Diagnostics reported record fourth quarter revenues of $1.93 billion, up 4.8% versus 2018. Diluted earnings per share from continuing operations was $1.86, up 101.2% from 2018, and adjusted diluted EPS was $1.67, up 23.7% from 2018.
Record fourth quarter revenues of $1.93 billion, up 4.8% versus 2018
Record fourth quarter diluted earnings per share from continuing operations ("EPS") of $1.86, up 101.2% from 2018 primarily due to a gain associated with the sale and leaseback of a property
Record adjusted diluted EPS of $1.67, up 23.7% from 2018
Board of Directors authorized a 5.7% increase in its quarterly dividend from $0.53 to $0.56 per share
Quest Diagnostics
Quest Diagnostics
Quest Diagnostics Revenue by Segment
Forward Guidance
The company estimates full year 2020 results as follows: Net revenues $7.80 billion - $7.96 billion. Reported diluted EPS Greater than $5.51. Adjusted diluted EPS Greater than $6.60. Cash provided by operations $1.25 billion - $1.30 billion. Capital expenditures $375 million - $400 million.
Positive Outlook
- Net revenues $7.80 billion - $7.96 billion
- Net revenues increase 1.0% - 3.0%
- Reported diluted EPS Greater than $5.51
- Adjusted diluted EPS Greater than $6.60
- Cash provided by operations $1.25 billion - $1.30 billion
Challenges Ahead
- Capital expenditures $375 million - $400 million